{"description":"Documents matching 'compliance guide secg intended help'","count":63,"total_pages":4,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=compliance+guide+secg+intended+help&format=json&page=2","results":[{"title":"Mammography Quality Standards Act and Regulation Amendments: Small Entity Compliance Guide; Guidance for Industry and Food and Drug Administration Staff; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA or the Agency) is announcing the availability of a guidance for industry entitled \"Mammography Quality Standards Act and Regulation Amendments: Small Entity Compliance Guide.\" The Mammography Quality Standards Act of 1992 (MQSA) final rule amended FDA's regulations to address, among other things, standards for accreditation bodies, certifying agencies, mammography equipment, quality assurance testing, and clinical image quality, as well as to require certain breast density information be provided by mammography facilities to patients and their healthcare providers. The small entity compliance guide (SECG) is intended to help small entities comply with the MQSA final rule.","document_number":"2024-19059","html_url":"https://www.federalregister.gov/documents/2024/08/26/2024-19059/mammography-quality-standards-act-and-regulation-amendments-small-entity-compliance-guide-guidance","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-08-26/pdf/2024-19059.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-19059.pdf?1724417123","publication_date":"2024-08-26","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"and Regulation Amendments: Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The Mammography Quality Standards Act of 1992 (MQSA) final rule amended FDA's regulations to address, among other things, standards for accreditation bodies, certifying agencies, mammography equipment, quality assurance testing, and clinical image quality, as well as to require certain breast density information be provided by mammography facilities to patients and their healthcare providers. The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with the MQSA final"},{"title":"Revocation of Uses of Partially Hydrogenated Oils in Foods: Guidance for Industry; Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA or we) is announcing the availability of a guidance for industry entitled \"Revocation of Uses of Partially Hydrogenated Oils in Foods: Guidance for Industry; Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entities comply with our regulations after we revoked specific requirements pertaining to the use of partially hydrogenated oils in certain foods or as a direct or indirect food substance.","document_number":"2024-08955","html_url":"https://www.federalregister.gov/documents/2024/04/29/2024-08955/revocation-of-uses-of-partially-hydrogenated-oils-in-foods-guidance-for-industry-small-entity","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-04-29/pdf/2024-08955.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-08955.pdf?1714135520","publication_date":"2024-04-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"availability. \n \n \n SUMMARY: \n The Food and Drug Administration (FDA or we) is announcing the availability of a guidance for industry entitled “Revocation of Uses of Partially Hydrogenated Oils in Foods: Guidance for Industry; Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with our regulations after we revoked specific requirements pertaining to the use of partially hydrogenated oils in certain foods or as a direct or indirect food substance. \n \n \n DATES: \n \n The announcement of the"},{"title":"Laboratory Developed Tests: Small Entity Compliance Guide; Guidance for Laboratory Manufacturers and Food and Drug Administration Staff; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled \"Laboratory Developed Tests: Small Entity Compliance Guide.\" The laboratory developed tests (LDT) final rule amended FDA's regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act (FD&C Act) including when the manufacturer of the IVD is a laboratory. This small entity compliance guide (SECG) is intended to help small entities comply with applicable medical device regulations, consistent with the LDT final rule, including the phasing out of FDA's general enforcement discretion approach for LDTs so that IVDs manufactured by a laboratory will generally fall under the same enforcement approach as other IVDs.","document_number":"2024-13872","html_url":"https://www.federalregister.gov/documents/2024/06/25/2024-13872/laboratory-developed-tests-small-entity-compliance-guide-guidance-for-laboratory-manufacturers-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-06-25/pdf/2024-13872.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-13872.pdf?1719233120","publication_date":"2024-06-25","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"is announcing the availability of a final guidance entitled “Laboratory Developed Tests: Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The laboratory developed tests (LDT) final rule amended FDA's regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) including when the manufacturer of the IVD is a laboratory. This small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with applicable medical device regulations, consistent with the LDT final rule,"},{"title":"Requirements for Additional Traceability Records for Certain Foods: What You Need To Know About the Food and Drug Administration Regulation: Guidance for Industry; Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a guidance for industry entitled \"Requirements for Additional Traceability Records for Certain Foods: What You Need to Know About the FDA Regulation: Guidance for Industry-- Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entities comply with the final rule entitled \"Requirements for Additional Traceability Records for Certain Foods.\"","document_number":"2023-10666","html_url":"https://www.federalregister.gov/documents/2023/05/19/2023-10666/requirements-for-additional-traceability-records-for-certain-foods-what-you-need-to-know-about-the","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-05-19/pdf/2023-10666.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-10666.pdf?1684413927","publication_date":"2023-05-19","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"the Agency, or we) is announcing the availability of a guidance for industry entitled “Requirements for Additional Traceability Records for Certain Foods: What You Need to Know About the FDA Regulation: Guidance for Industry—Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with the final rule entitled “Requirements for Additional Traceability Records for Certain Foods.” \n \n \n DATES: \n \n The announcement of the guidance is published in the \n Federal Register \n on May 19, 2023.\n \n \n \n"},{"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; New Animal Drugs for Minor Use and Minor Species","type":"Notice","abstract":"The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.","document_number":"2026-13005","html_url":"https://www.federalregister.gov/documents/2026/06/29/2026-13005/agency-information-collection-activities-submission-for-office-of-management-and-budget-review","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-29/pdf/2026-13005.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13005.pdf?1782477909","publication_date":"2026-06-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"for Minor Uses and for Minor Species \n • CVM GFI #170—Animal Drug User Fees and Fee Waivers and Reductions \n • CVM GFI #200—<span class=\"match\">SECG</span> for Designation of New Animal Drugs for Minor Uses/Minor Species \n • CVM GFI #201—<span class=\"match\">SECG</span> for Index of Legally Marketed Unapproved New Animal Drugs for Minor Species \n In addition, we are currently revising CVM GFI#210—The Index of Legally Marketed Unapproved New Animal Drugs for Minor Species to <span class=\"match\">help</span> companies navigate the indexing process. \n FDA estimates the burden of this collection of information as follows: \n \n \n Table"},{"title":"Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance entitled \"Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/ Ps): Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entity establishments that manufacture HCT/Ps better understand the comprehensive regulatory framework for HCT/Ps set forth in the regulations and comply with certain HCT/P- related final rules. The SECG announced in this notice supersedes the SECG of the same title dated August 2007.","document_number":"2022-23573","html_url":"https://www.federalregister.gov/documents/2022/11/01/2022-23573/regulation-of-human-cells-tissues-and-cellular-and-tissue-based-products-small-entity-compliance","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-11-01/pdf/2022-23573.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-23573.pdf?1667220319","publication_date":"2022-11-01","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"entitled “Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entity establishments that manufacture HCT/Ps better understand the comprehensive regulatory framework for HCT/Ps set forth in the regulations and comply with certain HCT/P-related final rules. The <span class=\"match\">SECG</span> announced in this notice supersedes the <span class=\"match\">SECG</span> of the same title dated August 2007. \n \n \n DATES: \n \n The announcement of the guidance is published in the \n"},{"title":"Laboratory Accreditation for Analyses of Foods; Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a guidance for industry entitled \"Laboratory Accreditation for Analyses of Foods: What You Need to Know About the FDA Regulation: Guidance for Industry--Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entities comply with the final rule entitled \"Laboratory Accreditation for Analyses of Foods.\"","document_number":"2022-22706","html_url":"https://www.federalregister.gov/documents/2022/10/20/2022-22706/laboratory-accreditation-for-analyses-of-foods-small-entity-compliance-guide-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-10-20/pdf/2022-22706.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-22706.pdf?1666183520","publication_date":"2022-10-20","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Administration (FDA, the Agency, or we) is announcing the availability of a guidance for industry entitled “Laboratory Accreditation for Analyses of Foods: What You Need to Know About the FDA Regulation: Guidance for Industry—Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with the final rule entitled “Laboratory Accreditation for Analyses of Foods.” \n \n \n DATES: \n \n The announcement of the guidance is published in the \n Federal Register \n on October 20, 2022.\n \n \n \n ADDRESSES: \n You"},{"title":"Retirement Security Rule: Definition of an Investment Advice Fiduciary","type":"Rule","abstract":"The Department of Labor (Department) is adopting a final rule defining when a person renders \"investment advice for a fee or other compensation, direct or indirect\" with respect to any moneys or other property of an employee benefit plan, for purposes of the definition of a \"fiduciary\" in the Employee Retirement Income Security Act of 1974 (Title I of ERISA or the Act). The final rule also applies for purposes of Title II of ERISA to the definition of a fiduciary of a plan defined in Internal Revenue Code (Code), including an individual retirement account or other plan identified in the Code. The Department also is publishing elsewhere in this issue of the Federal Register amendments to Prohibited Transaction Exemption 2020-02 (Improving Investment Advice for Workers & Retirees) and to several other existing administrative exemptions from the prohibited transaction rules applicable to fiduciaries under Title I and Title II of ERISA.","document_number":"2024-08065","html_url":"https://www.federalregister.gov/documents/2024/04/25/2024-08065/retirement-security-rule-definition-of-an-investment-advice-fiduciary","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-04-25/pdf/2024-08065.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-08065.pdf?1713962724","publication_date":"2024-04-25","agencies":[{"raw_name":"DEPARTMENT OF LABOR","name":"Labor Department","id":271,"url":"https://www.federalregister.gov/agencies/labor-department","json_url":"https://www.federalregister.gov/api/v1/agencies/271","parent_id":null,"slug":"labor-department"},{"raw_name":"Employee Benefits Security Administration","name":"Employee Benefits Security Administration","id":131,"url":"https://www.federalregister.gov/agencies/employee-benefits-security-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/131","parent_id":271,"slug":"employee-benefits-security-administration"}],"excerpts":"the <span class=\"match\">compliance</span> burden on investment advice fiduciaries and has taken care to ensure that the <span class=\"match\">compliance</span> obligations—which generally involve adherence to fundamental obligations of fair dealing—align with the conduct standards adopted by the SEC and other regulators. These regulators too have moved to more protective standards in recent years, so that the Department's actions are consistent with the broad trend in the regulatory landscape. The Department has also taken care to ensure that to the extent that providers had implemented <span class=\"match\">compliance</span> with"},{"title":"Commodity Pool Operators, Commodity Trading Advisors, and Commodity Pools: Updating the `Qualified Eligible Person' Definition; Adding Minimum Disclosure Requirements for Pools and Trading Programs; Permitting Monthly Account Statements for Funds of Funds; Technical Amendments","type":"Proposed Rule","abstract":"The Commodity Futures Trading Commission (Commission or CFTC) is proposing amendments to certain provisions of its regulations that would: update the Portfolio Requirement thresholds within the \"Qualified Eligible Person\" definition; require commodity pool operators (CPOs) and commodity trading advisors (CTAs) operating pools and trading programs under the applicable Commission regulations to provide certain minimum disclosures to their prospective pool participants and advisory clients; include revisions that are consistent with long-standing Commission exemptive letters addressing the timing of certain pools' periodic financial reporting; and several technical amendments related to the structure of the regulations that are the subject of this proposal.","document_number":"2023-22324","html_url":"https://www.federalregister.gov/documents/2023/10/12/2023-22324/commodity-pool-operators-commodity-trading-advisors-and-commodity-pools-updating-the-qualified","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-10-12/pdf/2023-22324.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-22324.pdf?1697028325","publication_date":"2023-10-12","agencies":[{"raw_name":"COMMODITY FUTURES TRADING COMMISSION","name":"Commodity Futures Trading Commission","id":77,"url":"https://www.federalregister.gov/agencies/commodity-futures-trading-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/77","parent_id":null,"slug":"commodity-futures-trading-commission"}],"excerpts":"reasonable steps to verify their accredited investor status. \n See also \n Registration and <span class=\"match\">Compliance</span> Requirements for Commodity Pool Operators and Commodity Trading Advisors, 83 FR 52902, 52909-11 (Oct. 18, 2018); “Eliminating the Prohibition Against General Solicitation and General Advertising in Rule 506 and Rule 144A Offerings,” A Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>, SEC, \n available at https://www.sec.gov/info/smallbus/<span class=\"match\">secg</span>/general-solicitation-small-entity-<span class=\"match\">compliance</span>-<span class=\"match\">guide</span>. \n When relying on the exemption in Regulation 506(c), offerors today may comfortably"},{"title":"Requirements for Additional Traceability Records for Certain Foods","type":"Rule","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is issuing a final rule establishing additional recordkeeping requirements for persons who manufacture, process, pack, or hold foods the Agency has designated for inclusion on the Food Traceability List (FTL). The final rule adopts provisions requiring these entities to maintain records containing information on critical tracking events in the supply chain for these designated foods, such as initially packing, shipping, receiving, and transforming these foods. The requirements established in the final rule will help the Agency rapidly and effectively identify recipients of foods to prevent or mitigate foodborne illness outbreaks and address credible threats of serious adverse health consequences or death resulting from foods being adulterated or misbranded. We are issuing this regulation in accordance with the FDA Food Safety Modernization Act (FSMA).","document_number":"2022-24417","html_url":"https://www.federalregister.gov/documents/2022/11/21/2022-24417/requirements-for-additional-traceability-records-for-certain-foods","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-11-21/pdf/2022-24417.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-24417.pdf?1668528919","publication_date":"2022-11-21","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"communications. Nevertheless, we understand that coming into <span class=\"match\">compliance</span> with the final rule might pose more challenges for entities with fewer resources and less experience in traceability, and we intend to provide outreach and guidance to <span class=\"match\">help</span> smaller entities understand and comply with the applicable requirements of the final rule. In addition, in accordance with section 204(h) of FSMA, not later than 180 days after promulgation of this final rule we will issue a small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) that explains the requirements of subpart S in plain"},{"title":"Retirement Security Rule: Definition of an Investment Advice Fiduciary","type":"Proposed Rule","abstract":"This document contains a proposed amendment to the regulation defining when a person renders \"investment advice for a fee or other compensation, direct or indirect\" with respect to any moneys or other property of an employee benefit plan, for purposes of the definition of a \"fiduciary\" in the Employee Retirement Income Security Act of 1974 (Title I of ERISA or the Act). The proposal also would amend the parallel regulation defining for purposes of Title II of ERISA, a \"fiduciary\" of a plan defined in Internal Revenue Code (Code) section 4975, including an individual retirement account. The Department also is publishing elsewhere in today's Federal Register proposed amendments to Prohibited Transaction Exemption 2020-02 (Improving Investment Advice for Workers & Retirees) and to several other existing administrative exemptions from the prohibited transaction rules applicable to fiduciaries under Title I and Title II of ERISA.","document_number":"2023-23779","html_url":"https://www.federalregister.gov/documents/2023/11/03/2023-23779/retirement-security-rule-definition-of-an-investment-advice-fiduciary","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-11-03/pdf/2023-23779.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-23779.pdf?1698929122","publication_date":"2023-11-03","agencies":[{"raw_name":"DEPARTMENT OF LABOR","name":"Labor Department","id":271,"url":"https://www.federalregister.gov/agencies/labor-department","json_url":"https://www.federalregister.gov/api/v1/agencies/271","parent_id":null,"slug":"labor-department"},{"raw_name":"Employee Benefits Security Administration","name":"Employee Benefits Security Administration","id":131,"url":"https://www.federalregister.gov/agencies/employee-benefits-security-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/131","parent_id":271,"slug":"employee-benefits-security-administration"}],"excerpts":"reasonably designed to address conflicts of interest associated with its recommendations to retail customers; and a <span class=\"match\">Compliance</span> Obligation, which requires broker-dealers to establish, maintain and enforce written policies and procedures reasonably designed to achieve <span class=\"match\">compliance</span> with Regulation Best Interest as a whole.\n 250 \n \n \n \n \n 250 \n  SEC's Office of <span class=\"match\">Compliance</span> Inspections and Examinations, \n Examinations that Focus on <span class=\"match\">Compliance</span> with Regulation Best Interest, \n (April 7, 2020), \n https://www.sec.gov/files/Risk%20Alert-%20Regulation%20Best%20Interest%20Exams"},{"title":"Withdrawing Rule on Securing Updated and Necessary Statutory Evaluations Timely","type":"Rule","abstract":"The Department of Health and Human Services (HHS or Department) is issuing a final rule withdrawing a rule entitled \"Securing Updated and Necessary Statutory Evaluations Timely\" (SUNSET final rule), which published in the Federal Register of January 19, 2021. The SUNSET final rule was originally scheduled to take effect on March 22, 2021. However, after a lawsuit was filed on March 9, 2021, seeking to overturn the SUNSET final rule, HHS extended the effective date of the SUNSET final rule until September 22, 2022. HHS is now withdrawing the SUNSET final rule.","document_number":"2022-11477","html_url":"https://www.federalregister.gov/documents/2022/05/27/2022-11477/withdrawing-rule-on-securing-updated-and-necessary-statutory-evaluations-timely","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-05-27/pdf/2022-11477.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-11477.pdf?1653569128","publication_date":"2022-05-27","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"},{"raw_name":"Public Health Service","name":"Public Health Service","id":442,"url":"https://www.federalregister.gov/agencies/public-health-service","json_url":"https://www.federalregister.gov/api/v1/agencies/442","parent_id":221,"slug":"public-health-service"},{"raw_name":"Centers for Medicare and Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"},{"raw_name":"Office of the Inspector General"},{"raw_name":"Office of the Secretary"},{"raw_name":"Administration for Children and Families","name":"Children and Families Administration","id":49,"url":"https://www.federalregister.gov/agencies/children-and-families-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/49","parent_id":221,"slug":"children-and-families-administration"}],"excerpts":"directive that HHS publish a plan to periodically review its code of regulations.”\n \n \n Response: \n HHS disagrees that maintaining the SUNSET final rule is necessary to prevent non-<span class=\"match\">compliance</span> with the RFA. In Section V.C.2, the Department discussed its <span class=\"match\">compliance</span> with the RFA, including <span class=\"match\">compliance</span> with the “plan” requirement under section 610(a). In light of this <span class=\"match\">compliance</span>, to the extent that the Take Care Clause, Supremacy Clause, or separation-of-powers doctrine are implicated here, the President and the Department have fully discharged their responsibilities"},{"title":"Public Company Accounting Oversight Board; Notice of Filing of Proposed Rules on Planning and Supervision of Audits Involving Other Auditors and Dividing Responsibility for the Audit With Another Accounting Firm","type":"Notice","abstract":null,"document_number":"2022-13983","html_url":"https://www.federalregister.gov/documents/2022/07/01/2022-13983/public-company-accounting-oversight-board-notice-of-filing-of-proposed-rules-on-planning-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-07-01/pdf/2022-13983.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-13983.pdf?1656593113","publication_date":"2022-07-01","agencies":[{"raw_name":"SECURITIES AND EXCHANGE COMMISSION","name":"Securities and Exchange Commission","id":466,"url":"https://www.federalregister.gov/agencies/securities-and-exchange-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/466","parent_id":null,"slug":"securities-and-exchange-commission"}],"excerpts":"written affirmations \n 56 \n \n regarding (1) the other auditor's policies and procedures regarding independence and ethics requirements and, if there are none, a description of how it determines its <span class=\"match\">compliance</span>; (2) the other auditor's <span class=\"match\">compliance</span> with independence and ethics requirements, which also describe the nature of any instances of non-<span class=\"match\">compliance</span>; and (3) a description of all relationships between the other auditor and the audit client or persons in financial reporting oversight roles that may reasonably be thought to bear on independence. (AS"},{"title":"Securing Updated and Necessary Statutory Evaluations Timely; Proposal To Withdraw or Repeal","type":"Proposed Rule","abstract":"The Department of Health and Human Services (HHS or Department) is proposing to withdraw or repeal a final rule entitled \"Securing Updated and Necessary Statutory Evaluations Timely\" (SUNSET final rule) and published in the Federal Register of January 19, 2021. The SUNSET final rule was originally scheduled to take effect on March 22, 2021. However, after a lawsuit was filed on March 9, 2021, seeking to overturn the SUNSET final rule, HHS issued an administrative delay of effective date that extended the effective date of the SUNSET final rule until March 22, 2022. HHS is now proposing to withdraw or repeal the SUNSET final rule.","document_number":"2021-23472","html_url":"https://www.federalregister.gov/documents/2021/10/29/2021-23472/securing-updated-and-necessary-statutory-evaluations-timely-proposal-to-withdraw-or-repeal","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-10-29/pdf/2021-23472.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-23472.pdf?1635425124","publication_date":"2021-10-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"},{"raw_name":"Public Health Service","name":"Public Health Service","id":442,"url":"https://www.federalregister.gov/agencies/public-health-service","json_url":"https://www.federalregister.gov/api/v1/agencies/442","parent_id":221,"slug":"public-health-service"},{"raw_name":"Centers for Medicare and Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"},{"raw_name":"Office of the Inspector General"},{"raw_name":"Office of the Secretary"},{"raw_name":"Administration for Children and Families","name":"Children and Families Administration","id":49,"url":"https://www.federalregister.gov/agencies/children-and-families-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/49","parent_id":221,"slug":"children-and-families-administration"}],"excerpts":"Act. \n \n \n RFA \n Regulatory Flexibility Act. \n \n \n SAMSHA \n Substance Abuse and Mental Health Services Administration. \n \n \n SBA \n Small Business Administration. \n \n \n SEISNOSE \n Significant Economic Impact Upon a Substantial Number of Small Entities. \n \n \n <span class=\"match\">SECG</span> \n Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>. \n \n \n SUNSET \n Securing Updated and Necessary Statutory Evaluations Timely. \n \n \n UA \n Unified Agenda. \n \n \n III. Background \n The SUNSET final rule, if implemented, would significantly alter the operations of HHS with considerable repercussions for a diverse"},{"title":"Amendments to Class Prohibited Transaction Exemptions To Remove Credit Ratings Pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act","type":"Notice","abstract":"This document amends six class exemptions from prohibited transaction rules set forth in the Employee Retirement Income Security Act of 1974 (ERISA or the Act) and the Internal Revenue Code (the Code). The amended exemptions are Prohibited Transaction Exemptions (PTEs) 75-1, 80-83, 81-8, 95-60, 97-41 and 2006-16. The amendments relate to the use of credit ratings as conditions in these class exemptions. Section 939A of the Dodd-Frank Wall Street Reform and Consumer Protection Act requires the Department to remove any references to or requirements of reliance on credit ratings from its class exemptions and to substitute standards of creditworthiness as the Department determines to be appropriate. The amendments affect participants and beneficiaries of employee benefit plans, owners of individual retirement accounts (IRAs), fiduciaries of employee benefit plans and IRAs, and the financial institutions that engage in transactions with, or provide services or products to, the plans and IRAs.","document_number":"2022-04866","html_url":"https://www.federalregister.gov/documents/2022/03/08/2022-04866/amendments-to-class-prohibited-transaction-exemptions-to-remove-credit-ratings-pursuant-to-the","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-03-08/pdf/2022-04866.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-04866.pdf?1646660733","publication_date":"2022-03-08","agencies":[{"raw_name":"DEPARTMENT OF LABOR","name":"Labor Department","id":271,"url":"https://www.federalregister.gov/agencies/labor-department","json_url":"https://www.federalregister.gov/api/v1/agencies/271","parent_id":null,"slug":"labor-department"},{"raw_name":"Employee Benefits Security Administration","name":"Employee Benefits Security Administration","id":131,"url":"https://www.federalregister.gov/agencies/employee-benefits-security-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/131","parent_id":271,"slug":"employee-benefits-security-administration"}],"excerpts":"Rating Organizations: A Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>, Feb. 4, 2014, available at \n https://www.sec.gov/info/smallbus/<span class=\"match\">secg</span>/5b-3-small-entity-<span class=\"match\">compliance</span>-guide.htm. \n \n \n \n \n 23 \n  66 FR 36156, 36161 (July 11, 2001).\n \n \n \n \n 24 \n  79 FR 1316, 1329 (January 8, 2014) (amending 17 CFR 270.5b-3(c)(1)(iv)(C)(1)).\n \n \n \n \n 25 \n  \n Id. \n at 1329, (amending 17 CFR 270.5b-3(c)(1)(iv)(C)(2)).\n \n \n \n \n 26 \n  See References to Ratings of Nationally Recognized Statistical Rating Organizations: A Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>, Feb. 4, 2014, available at \n https://www"},{"title":"Classification of Posterior Cervical Screw Systems: Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a final guidance for industry entitled \"Classification of Posterior Cervical Screw Systems: Small Entity Compliance Guide.\" This small entity compliance guide (SECG) is intended to help small entities comply with the final rule on the classification of posterior cervical screw systems.","document_number":"2020-09188","html_url":"https://www.federalregister.gov/documents/2020/05/04/2020-09188/classification-of-posterior-cervical-screw-systems-small-entity-compliance-guide-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-05-04/pdf/2020-09188.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-09188.pdf?1588337136","publication_date":"2020-05-04","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Notification of availability. \n \n \n SUMMARY: \n The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a final guidance for industry entitled “Classification of Posterior Cervical Screw Systems: Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” This small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with the final rule on the classification of posterior cervical screw systems. \n \n \n DATES: \n \n The announcement of the guidance is published in the \n Federal Register \n on May 4, 2020.\n \n \n \n ADDRESSES: \n You may"},{"title":"Food Labeling: Revision of the Nutrition and Supplement Facts Labels; Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA or we) is announcing the availability of a guidance for industry entitled \"Food Labeling: Revision of the Nutrition and Supplement Facts Labeling--Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entities comply with a final rule we issued in the Federal Register of May 27, 2016, entitled \"Food Labeling: Revision of the Nutrition and Supplement Facts Labeling.\"","document_number":"2020-01165","html_url":"https://www.federalregister.gov/documents/2020/02/04/2020-01165/food-labeling-revision-of-the-nutrition-and-supplement-facts-labels-small-entity-compliance-guide","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-02-04/pdf/2020-01165.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-01165.pdf?1580737515","publication_date":"2020-02-04","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Notification of availability. \n \n \n SUMMARY: \n \n The Food and Drug Administration (FDA or we) is announcing the availability of a guidance for industry entitled “Food Labeling: Revision of the Nutrition and Supplement Facts Labeling—Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with a final rule we issued in the \n Federal Register \n of May 27, 2016, entitled “Food Labeling: Revision of the Nutrition and Supplement Facts Labeling.”\n \n \n \n DATES: \n \n The announcement of the guidance is published"},{"title":"Section 503A Bulks List Final Rule Questions and Answers; Guidance for Industry; Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a guidance for industry entitled \"Section 503A Bulks List Final Rule Questions and Answers--Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entities comply with the final rule establishing the list of bulk drug substances that can be used in accordance with certain compounding provisions of the Federal Food, Drug, and Cosmetic Act (FD&C Act).","document_number":"2019-10953","html_url":"https://www.federalregister.gov/documents/2019/05/24/2019-10953/section-503a-bulks-list-final-rule-questions-and-answers-guidance-for-industry-small-entity","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-05-24/pdf/2019-10953.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-10953.pdf?1558615532","publication_date":"2019-05-24","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Notification of availability. \n \n \n SUMMARY: \n The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a guidance for industry entitled “Section 503A Bulks List Final Rule Questions and Answers—Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with the final rule establishing the list of bulk drug substances that can be used in accordance with certain compounding provisions of the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act). \n \n \n DATES: \n \n The"},{"title":"Antimicrobial Animal Drug Sales and Distribution Reporting; Small Entity Compliance Guide; Availability","type":"Rule","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a final guidance for industry #252 entitled \"Antimicrobial Animal Drug Sales and Distribution Reporting Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entities comply with the final rule we issued in the Federal Register of May 11, 2016, entitled \"Antimicrobial Animal Drug Sales and Distribution Reporting.\"","document_number":"2018-14085","html_url":"https://www.federalregister.gov/documents/2018/06/29/2018-14085/antimicrobial-animal-drug-sales-and-distribution-reporting-small-entity-compliance-guide","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2018-06-29/pdf/2018-14085.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2018-14085.pdf?1530189940","publication_date":"2018-06-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"availability. \n \n \n SUMMARY: \n \n The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a final guidance for industry #252 entitled “Antimicrobial Animal Drug Sales and Distribution Reporting Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with the final rule we issued in the \n Federal Register \n of May 11, 2016, entitled “Antimicrobial Animal Drug Sales and Distribution Reporting.”\n \n \n \n DATES: \n \n The announcement of the guidance is published in the"},{"title":"Registration of Food Facilities: What You Need To Know About the Food and Drug Administration Regulation; Small Entity Compliance Guide; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or we) is announcing the availability of a final guidance for industry entitled \"Registration of Food Facilities: What You Need To Know About the FDA Regulation-- Small Entity Compliance Guide.\" The small entity compliance guide (SECG) is intended to help small entities comply with a final rule we issued in the Federal Register of July 14, 2016, entitled \"Amendments to Registration of Food Facilities.\" The final rule amends the registration of food facilities regulations.","document_number":"2018-11419","html_url":"https://www.federalregister.gov/documents/2018/05/29/2018-11419/registration-of-food-facilities-what-you-need-to-know-about-the-food-and-drug-administration","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2018-05-29/pdf/2018-11419.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2018-11419.pdf?1527252325","publication_date":"2018-05-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"availability. \n \n \n SUMMARY: \n \n The Food and Drug Administration (FDA or we) is announcing the availability of a final guidance for industry entitled “Registration of Food Facilities: What You Need To Know About the FDA Regulation—Small Entity <span class=\"match\">Compliance</span> <span class=\"match\">Guide</span>.” The small entity <span class=\"match\">compliance</span> <span class=\"match\">guide</span> (<span class=\"match\">SECG</span>) is <span class=\"match\">intended</span> to <span class=\"match\">help</span> small entities comply with a final rule we issued in the \n Federal Register \n of July 14, 2016, entitled “Amendments to Registration of Food Facilities.” The final rule amends the registration of food facilities regulations.\n \n \n \n DATES:"}]}